PD-L1 Dysregulation in COVID-19 Patients

PD-L1 Dysregulation in COVID-19 Patients

The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-cr...

Full description

Bibliographic Details
Main Authors: Francesco Sabbatino, Valeria Conti, Gianluigi Franci, Carmine Sellitto, Valentina Manzo, Pasquale Pagliano, Emanuela De Bellis, Alfonso Masullo, Francesco Antonio Salzano, Alessandro Caputo, Ilaria Peluso, Pio Zeppa, Giosuè Scognamiglio, Giuseppe Greco, Carla Zannella, Michele Ciccarelli, Claudia Cicala, Carmine Vecchione, Amelia Filippelli, Stefano Pepe
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
PD-L1
immune checkpoint molecules
innate immune response
adaptive immune response
COVID-19
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.695242/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.695242/full

Similar Items